Summary
?The University of Tokyo, a national university (main campus: Bunkyo-ku, Tokyo; President: Junichi Hamada), Tokyo Institute of Technology, a national university (main campus: Meguro-ku, Tokyo; President: Yoshinao Mishima),MRC National Institute for Medical Research (London, U.K. Director: Jim Smith), and SBI Pharmaceuticals Co., Ltd. (head office: Minato-ku, Tokyo; Representative Director and CEO: Yoshitaka Kitao; “SBI Pharmaceuticals”), presented their findings in The Journal of Biochemistry (2 December 2013) regarding the working mechanism of 5-aminolevulinic acid (5-ALA) and bivalent iron in inhibiting the growth of Plasmodium falciparum (P. falciparum) malaria parasites.
The details of research